Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: Implications for the regulation of apoptosis in liver endothelial cells

FASEB Journal

Volumn 13, Issue 14, 1999, Pages 1950-1960

  Cardier, Jose E ^a   Schulte, Tara ^b   Kammer, Heide ^b   Kwak, Jenny ^b   Cardier, Marisabel ^c  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b Cancer Prevention Institute Dayton   (United States)

^c Hospital Risquez   (Venezuela)

Author keywords

Fas L; HUVEC; LEC I; Liver

Indexed keywords

DACTINOMYCIN; FAS ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; IMMUNOREGULATION; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; MURINAE;

EID: 0032730213     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.14.1950     Document Type: Article

References (54)

1. Nagata, S., and Golstein, P. (1995) The Fas death factor. Science 267, 1449-1456
2. Oehm, A., Berhmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richard, S., Dhein J., Trauth, B., Ponstingl, H., and Krammer, P. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. Biol. Chem. 267, 10709-10715
3. Watanabe-Fukunaga, R., Brannan, C., Itoh, N., Yonehara, S., Copeland, N., Jenkins, N., and Nagata, S. (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279
4. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis family. Cell 75, 1169-1178
5. Liles, W., Kiener, P., Ledbetter, J., Aruffo, A., and Klebanoff, S. (1996) Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429-440
6. Richardson, B., Lalwani, N., Johnson, K., and Marks, R. (1994) Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol. 24, 2640-2645
7. Suda, T., Okazaki, T., Naito, Y., Tokota, T., Arai, N., Ozaki, S., Nakao, S., and Nagata, S. (1995) Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154, 3806-3813
8. Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355-365
9. Wong, G., and Goeddel, D. (1994) Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152, 1751-1755
10. Clément, M., and Stamenkovic, I. (1994) Fas and tumor necrosis factor receptor-mediated cell death: similarities and distinctions. J. Exp. Med. 180, 557-567
11. Debatin, K., Sūss, D., and Krammer, P. (1994) Differential expression of APO-1 on human thymocytes: implications for negative selection? Eur. J. Immunol. 24, 753-758
12. Oshimi, Y., Oda, S., Honda, Y., Nagata, S., and Miyazaki, S. (1996) Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells. J. Immunol. 157, 2909-2915
13. Tsutsui, H., Nakanishi, K., Matsui, K., Higashino, K., Okamura, H., Miyazawa, Y., and Kaneda, K. (1996) IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157, 3967-3973
14. Tanaka, M., Suda, T., Takahashi, T., and Nagata, S. (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135
15. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A., and Nagata, S. (1996) Fas ligand in human serum. Nat. Med. 2, 317-322
16. Gibbons, G., and Dzau, V. (1994) The emerging concept of vascular remodeling. N. Engl. J. Med. 330, 1431-1438
17. Mohan, R., Lieng, Q., Kim, W., Helena, M., Baerveldt, F., and Wilson, S. (1997) Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Exp. Eye Res. 65, 575-589
18. Dong, C., Wilson, J., Winters, G., and McManus, B. (1996) Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab. Invest. 74, 921-931
19. Biancone, L., De Martino, A., Orlandi, V., Conaldi, P., Toniolo, A., and Camussi, G. (1997) Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp. Med. 186, 147-152
20. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993) Lethal effect of the anti-Fas antibody in mice. Nature (London) 364, 806-809
21. Müschen, M., Warskulat, U., Dovillard, P., Gilbert, E., and Häussinger, D. (1998) Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology 27, 200-208
22. Vidal-Vanaclocha, F., Rocha, M., Asumendi, A., Barberá-Guillem, E. (1993) Isolation and enrichment of two sublobular compartment-specific endothelial cell subpopulations from liver sinusoids. Hepatology 18, 328-339
23. Cardier, J., and Barberá-Guillem, E. (1997) Extramedullary hematopoiesis in the adult mouse liver is associated with specific hepatic sinusoidal endothelial cells. Hepatology 26, 165-175
24. Cardier, J. E., and Dempsey, J. (1998) Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: evidence of thrombopoietin as a growth factor for liver endothelial cells. Blood 91, 923-929
25. Trauth, B. C., Klas, C., Peters, A., Matzuku, S., Möller, P., Falk, W., Debatin, K., and Krammer, P. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305
26. Yonehara, S., Ishii, A., and Yonehara, M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756
27. Cohen, J. (1993) Apoptosis. Immunol. Today 14, 126-130
28. Koopman, G., Reutelingsperger, G., Kuitjen, R., Keehnen, R., Pals, S., and van Oers, M. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-1420
29. Fisher, GH., Rosemberg, F., Straus, S., Kale, J., Middleton, L., Lin, A., Strober, W., Lenardo, M., and Puck, J. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune disease lymphoproliferative syndrome. Cell 81, 935-946
30. Ni, R., Tomita, Y., Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J., and Nagata, S. (1994) Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res. 215, 332-337
31. Esser, P., Heimann, K., Abts, H., Fontana, A., and Weller, M. (1995) CD95 (Fas/APO-1) antibody mediated apoptosis of human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 213, 1026-1034
32. Mitra, D., Jaffe, E., Weksler, B., Hajjar, K., Soderland, C., and Laurence, J. (1997) Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 89, 1224-1234
33. Hartmann, K., Wagelie-Steffen, A., von Stebut, E., and Metcalfe, D. (1997) Fas (CD95, APO-1) antigen expression and function in murine mast cells. J. Immunol. 159, 4006-4014
34. Rafi, A., Zeytun, A., Bradley, M., Sponenberg, D., Grayson, R., Nagarkatti, M., and Nagarkatti, P. (1998) Evidence for the involvement of Fas ligand and perform in the induction of vascular leak syndrome. J. Immunol. 161, 3077-3086
35. Rothstein, T., Wang, J., Panka, D., Foote, L., Wang, Z., Stanger, B., Cull, H., Ju, T., and Rothstein, A. (1995) Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature (London) 374, 163-165
36. Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y., and Fontana, A. (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94, 954-964
37. Vassalli, P. (1992) The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411-452
38. Orange, J., Salazar-Mather, T., Opal, S., and Biron, C. (1997) Mechanisms for virus induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection. J. Virol. 71, 9248-9258
39. Galle, P., Hofmann, W., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P., and Runkel, L. (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230
40. Machizuki, K., Hayashi, N., Hiramatsu, N., Katayama, K., Kawanishi, Y., Kasahara, A., Fusamoto, H., and Kamada, T. (1996) Fas antigen expression in liver tissues of patients with chronic hepatitis B. J. Hepatol. 24, 1-7
41. Hewett, J., Jean, P., Kunkel, and S., Roth, R. (1993) Relationship between tumor necrosis factor-(and neutrophils in endotoxin-induced liver injury. Am. J. Physiol. 265, G1011-G1015
42. Leist, M., Gantner, G., Jilg, S., and Wendel, A. (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis and nitrite release. J. Immunol. 154, 1307-1316
43. Nagaki, M., Muto, Y., Ohnishi, S., Yasuda, K., Sano, T., Naito, T., Maeda, T., Yamada, T., and Moriwaki, H. (1994) Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 106, 450-458
44. Pilaro, A., Taub, D., McCormick, K., Williams, H., Sayers, T., Fogler, W., and Wiltrout, R. (1994) TNF-α is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J. Immunol. 153, 333-342
45. Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R., and Galluzzo, A. (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275, 960-963
46. Urayama, S., Kawakami, A., Matsuoka, N., Tsuboi, M., Nakashima, T., Kawabe, Y., Koji, T., and Eguchi, K. (1997) Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells. Biochem. Biophys. Res. Commun. 239, 782-788
47. Alderson, M., Armitage, R., Maraskovsky, E., Tough, T., Roux, E., Schooley, K., Ramsdell, F., and Lynch, D. (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 2231-2235
48. Ponton, A., Clément, M., and Stamenkovic, I. (1996) The CD95 (APO-1/Fas) receptor activates NF κB independently of its cytotoxic function. J. Biol. Chem. 271, 8991-8995
49. Rensing E-Ehl, A., Hess, S., Ziegler-Heitbrock, H., Rietmuller, G., and Engelmann, H. (1995) Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production. J. Inflamm. 45, 161-174
50. Aggarwal, B., Singh, S., LaPushin, R., and Totpal, K. (1995) Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364, 5-8
51. Henkart, P. A. (1996) ICE family proteases: mediators of all apoptotic cell death? Immunity 4, 195-201
52. Longthorne, V., and Williams, G. (1997) Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J. 16, 3805-3812
53. Green, D. R. (1998) Apoptotic pathway: the roads to ruin. Cell 94, 695-698
54. Leist, M., Gantner, F., Bolhlinger, I., Germann, P., Tiegs, G., and Wendel, A. (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-(requires transcriptional arrest. J. Immunol. 153, 1778-1788